XML 54 R38.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 18, 2024
Apr. 28, 2021
Apr. 05, 2021
Jun. 30, 2022
May 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Jun. 15, 2023
Dec. 31, 2022
Jun. 04, 2021
May 31, 2019
Jun. 07, 2016
Subsidiary, Sale of Stock [Line Items]                        
Common stock, par value           $ 0.0001 $ 0.0001          
Warrant outstanding amount           $ 199,733 $ 199,733          
Stock options outstanding           208,288 408,288   608,288      
Weighted average exercise price           $ 0.456            
Weighted average contractual term remaining           7 months 17 days            
Stock options, granted           0            
Stock options, exercised           0            
Stock options, forfeited           200,000            
Stock-based compensation expense           $ 0 $ 0          
Stock repurchase program, maximum amount           816,167         $ 1,000,000  
Stock repurchase program, number of shares       66,167 66,167              
Stock repurchase program, total purchase cost       $ 11,662 $ 11,662 $ 119,402            
Series B-1 Preferred Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Preferred stock, shares authorized           5,000,000 5,000,000 5,000,000       3,333,333
Preferred stock, par value           $ 0.0001 $ 0.0001         $ 0.0001
Working capital loan                   $ 750,000    
Shares issued 750,075                 7,500    
Cancellation agreement with related party promissory note $ 3,665,303                      
Liquidation preference, per share           $ 1.00            
Liquidation preference, value           $ 767,075 $ 15,000          
Warrant [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Total number of potentially dilutive common stock   199,733                    
Exercise price   $ 0.66                    
Private Placement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Total number of potentially dilutive common stock     2,496,667                  
Common stock, par value     $ 0.0001                  
Purchase price     $ 1,498,000                  
Proceeds from the private placement     1,498,000                  
Restricted shares of common stock     $ 1,498,000